Understanding the Market | TOUYUN BIOTECH falls over 28% Company responds to stock price fluctuations Subsidiary signs a 1 billion yuan procurement framework agreement for Rhein algae
TOUYUN BIOTECH's maximum cumulative increase over the previous three trading days was nearly 9 times. Today, the stock price fell by more than 28%, and as of the time of writing, it has dropped by 22%, trading at HKD 0.39, with a transaction volume of HKD 8.9506 million. In terms of news, TOUYUN BIOTECH issued a statement regarding the unusual fluctuations in stock price and trading volume, stating that its wholly-owned subsidiary Shanxi TOUYUN signed a strategic cooperation agreement on October 23 with Shenzhen Building Supply Chain Technology, Henan State-owned Marketing Management, and Beijing HeWanjia Biotechnology. According to this agreement, from 2026 to 2028, the sales consortium will purchase no less than RMB 1 billion worth of Rhodella and related products from Shanxi TOUYUN
According to Zhitong Finance APP, TOUYUN BIOTECH (01332) had a maximum cumulative increase of nearly 9 times over the previous three trading days. Today, the stock price fell more than 28%, and as of the time of writing, it has dropped 22%, trading at HKD 0.39, with a transaction volume of HKD 8.9506 million.
In terms of news, TOUYUN BIOTECH issued a statement regarding the unusual fluctuations in stock price and trading volume. Its wholly-owned subsidiary, Shanxi TOUYUN, signed a strategic cooperation agreement on October 23 with Shenzhen Building Supply Chain Technology, Henan State-owned Marketing Management, and Beijing HeWanjia Biotechnology. According to this agreement, from 2026 to 2028, the sales consortium will purchase no less than 1 billion RMB worth of Rhizoclonium and related products from Shanxi TOUYUN
